SIEGFRIED USA LLC

Overview

SIEGFRIED USA LLC is an active pharmaceutical ingredient (API) supplier with 37 active FDA Type II Drug Master Files, covering AMOBARBITAL SODIUM USP; AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; BUPRENORPHINE; BUPRENORPHINE HYDROCHLORIDE; BUPRENORPHINE HYDROCHLORIDE USP.

API / Drug Master Files

SIEGFRIED USA LLC holds 37 active (81 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• NALTREXONEActive2024-12-20
• BUPRENORPHINE HYDROCHLORIDEActive2024-02-29
• DETROAMPHETAMINE SULFATEActive2023-10-20
• DEXTROAMPHETAMINE SACCHARATEActive2023-08-01
• METHYLPHENIDATE HYDROCHLORIDE USPActive2019-12-18
• AMPHETAMINE ASPARTATEActive2016-02-25
• DEXTROAMPHETAMINE SACCHARATEActive2016-02-25
• AMPHETAMINE SULFATEActive2016-02-25
• DEXTROAMPHETAMINE SULFATEActive2016-02-25
• BUPRENORPHINEActive2015-03-02
• BUPRENORPHINEActive2012-05-14
• BUPRENORPHINE HYDROCHLORIDE USPActive2011-11-15
• NALOXONE HYDROCHLORIDE DIHYDRATEActive2011-02-24
• OXYCODONE HYDROCHLORIDE USPActive2010-02-04
• NALTREXONE HYDROCHLORIDEActive2009-10-21

Showing 15 of 81 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SIEGFRIED USA LLC in our records. PharmaTek screens the full directory against live FDA enforcement data.